Oxler Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$968K Hold
1,723
0.3% 42
2025
Q4
$1.17M Buy
1,723
+41
+2% +$27.9K 0.34% 38
2025
Q3
$1.07M Hold
1,682
0.31% 39
2025
Q2
$902K Hold
1,682
0.28% 45
2025
Q1
$706K Sell
1,682
-13
-0.8% -$5.64K 0.25% 49
2024
Q4
$701K Hold
1,695
0.23% 55
2024
Q3
$856K Hold
1,695
0.3% 46
2024
Q2
$826K Sell
1,695
-30
-2% -$15.1K 0.31% 47
2024
Q1
$931K Buy
1,725
+1,270
+279% +$694K 0.37% 46
2023
Q4
$253K Sell
455
-1,270
-74% -$596K 0.21% 65
2023
Q3
$754K Hold
1,725
0.38% 53
2023
Q2
$866K Hold
1,725
0.41% 52
2023
Q1
$863K Hold
1,725
0.43% 51
2022
Q4
$704K Hold
1,725
0.38% 59
2022
Q3
$562K Hold
1,725
0.31% 67
2022
Q2
$605K Buy
1,725
+1,270
+279% +$518K 0.29% 72
2022
Q1
$248K Hold
455
0.11% 101
2021
Q4
$299K Sell
455
-7
-2% -$4.39K 0.12% 106
2021
Q3
$287K Hold
462
0.13% 111
2021
Q2
$291K Hold
462
0.13% 114
2021
Q1
$226K Hold
462
0.11% 112
2020
Q4
$230K Buy
+462
New +$207K 0.13% 97

Other funds holding IDXX

Oxler Private Wealth's IDXX Position: Q1 2026 in Review

Oxler Private Wealth held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,723 shares worth $968K. The position accounts for 0.3% of the portfolio, ranked #42.

Oxler Private Wealth first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.17M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Oxler Private Wealth held 1,723 shares of Idexx Laboratories worth $968K as of Q1 2026.
  • Oxler Private Wealth left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.3% of Oxler Private Wealth's portfolio in Q1 2026, its #42 holding.
  • Oxler Private Wealth first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
  • Oxler Private Wealth's Idexx Laboratories position peaked at $1.17M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Oxler Private Wealth's 13F filing for Q1 2026, filed 28 Apr 2026.